Patient study using a newly developed amiloid imaging PET tracer: [18F]FPYBF-2
Not Applicable
- Conditions
- Dementia and its related diseases
- Registration Number
- JPRN-UMIN000012297
- Lead Sponsor
- Shiga Medical Center
- Brief Summary
Patient study is still going on in our center. Published at Annals of Nuclear Medicine (2018) 32:206-216 https;//doi.org/10.1007/s12149-018-1236-1
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
none
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of diagnostic usefulness of [18F]FPYBF-2 in patients who are clinically diagnosed as dementia and its related diseases (comparison between clinical diagnosis and imaging diagnosis).
- Secondary Outcome Measures
Name Time Method Evaluation of prognostic usefulness of [18F]FPYBF-2 in patients with mild cognitive imapairment who developed dementia later.